Assets, Current in USD of Ambrx Biopharma Cayman, Inc. from Q4 2020 to Q2 2023

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Ambrx Biopharma Cayman, Inc. quarterly Assets, Current history and change rate from Q4 2020 to Q2 2023.
Ambrx Biopharma Cayman, Inc. Assets, Current for the quarter ending 30 Jun 2023 was $241,413,000.000, a 99.5% increase year-over-year.

Assets, Current, Quarterly (USD)

Assets, Current, YoY Quarterly Change (%)

Ambrx Biopharma Cayman, Inc. Quarterly Assets, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2023	$241,413,000	+$120,407,000	+99.5%	30 Jun 2023	10-Q	09 Aug 2023
Q1 2023	$162,942,000			31 Mar 2023	10-Q	11 May 2023
Q4 2022	$90,583,000	-$86,223,000	-48.8%	31 Dec 2022	10-Q	09 Aug 2023
Q2 2022	$121,006,000			30 Jun 2022	6-K	29 Aug 2022
Q4 2021	$176,806,000	+$83,729,000	+90%	31 Dec 2021	10-K	30 Mar 2023
Q4 2020	$93,077,000			31 Dec 2020	20-F	26 Apr 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.